Literature DB >> 509413

Induction of aryl hydrocarbon hydroxylase in primary cultures of type II alveolar lung cells and binding of metabolically activated benzo[a]pyrene to nuclear macromolecules.

R W Teel.   

Abstract

Alveolar-like structures cultured on a gelatin sponge substrate are composed of cells resembling type II alveolar pneumonocytes. These cells contain aryl hydrocarbon hydroxylase (AHH) as determined by fluorescent measurements of water-soluble product from the metabolism of polycyclic aromatic hydrocarbons (PAH). Of 3 compounds tested, benzo[a]pyrene (BP) stimulates the highest level of AHH activity. Activity reaches a peak in 6 day cultures and remains relatively stable for a culture period of 12 days. Metabolites of tritium labeled BP interact with nuclear macromolecules in these cells as determined by measurements of 3H binding to DNA, histone and non-histone chromosomal proteins. A preferential binding to the non-histone protein fraction occurs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509413     DOI: 10.1016/s0304-3835(79)80065-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  3-Methylcholanthrene-induced ethoxyresorufin O-deethylase activity in alveolar type II cells of rabbit lung.

Authors:  Y Kitagawa; M Okamoto; T Sugiyama; H Kitamura; K Nakahara; Y Kawashima; T Yamano
Journal:  Arch Toxicol       Date:  1986-05       Impact factor: 5.153

2.  Role of inhalation studies with animals in defining human health risks for vehicle and power plant emissions.

Authors:  R O McClellan
Journal:  Environ Health Perspect       Date:  1983-01       Impact factor: 9.031

3.  Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats.

Authors:  Y Yokose; K Yamamoto; A Nakajima; H Eimoto; H Maruyama; Y Mori; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1988-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.